Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
VBI Vaccines Inc
VBIVCurrent price
0.018 USD
-0.0042 USD (-19.09%)
Last closed
0.018 USD
Company
www.vbivaccines.com
ISIN
CA91822J1030
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 872 954 USD
Yield for 12 month
-97.56 %
1Y
3Y
5Y
10Y
15Y
VBIV
VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts. Address: 160 Second Street, Cambridge, MA, United States, 02142
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
+8 682 000 USD
Last Year
+1 082 000 USD
Current Quarter
+1 214 000 USD
Last Quarter
+853 000 USD
Current Year
-5 815 000 USD
Last Year
-10 194 000 USD
Current Quarter
-1 510 000 USD
Last Quarter
-2 090 000 USD
Key Figures VBIV
1 year
3 years
5 years
10 years
EBITDA
-45 579 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-29.15 %
PEG Ratio
–
Return On Equity TTM
-419.59 %
Wall Street Target Price
5 USD
Revenue TTM
9 411 000 USD
Book Value
-0.22 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
150.3 %
Dividend Yield
–
Gross Profit TTM
-10 194 000 USD
Earnings per share
-3.54 USD
Diluted Eps TTM
-3.54 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VBIV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VBIV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
12.04.2023
Dividend Date
28.12.2012
Stock Valuation VBIV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
4.1051
Price Sales TTM
0.199
Enterprise Value EBITDA
-0.6885
Price Book MRQ
1.2356
Financials VBIV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VBIV
For 52 weeks
0.02 USD
1.06 USD
50 Day MA
0.48 USD
Shares Short Prior Month
416 988
200 Day MA
0.58 USD
Short Ratio
1.57
Shares Short
276 874
Short Percent
1.16 %
BeatStart